Walleye Capital LLC Cyma Bay Therapeutics, Inc. Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$10.86 - $17.62 $2.03 Million - $3.29 Million	-186,847 Reduced 79.63%	47,796 $712,000
Q2 2023 Aug 14, 2023	BUY	$7.47 - $10.95 $1.75 Million - $2.57 Million	234,643 New	234,643 $2.57 Million
Q4 2022 Feb 14, 2023	BUY	$3.22 - $6.27 $865,867 - $1.69 Million	268,903 Added 122.23%	488,894 $3.07 Million
Q3 2022 Nov 14, 2022	BUY	$2.77 - $4.25 $609,375 - $934,961	219,991 New	219,991 $770,000
Q3 2020 Nov 16, 2020	SELL	$3.32 - $7.24 $129,891 - $283,257	-39,124 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.41 - $4.25 $55,164 - $166,277	39,124 New	39,124 $137,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.